The non-collagenous N-terminal segment of type-I procollagen has been previously characterized as a strong antigen (Timpl et al., 1973; Kohn et al., 1974; vonder Mark etal., 1973; Rohde etal., 1976a,b) . This segment can be isolated from a collagenase digest of procollagen in form of the peptide Col 1, which has a molecular weight of about 10000 (Furthmayr et al., 1972; Becker et al., 1976) . Physical studies (Engel et al., 1977 ) indicated a rigid elongated structure of the peptide that is stabilized by five intrachain disulphide bridges. Two types of antigenic determinants are found in peptide Col 1 (Rohde et al., 1976b) . Most antibodies react with conformational determinants that can be destroyed by reducing the disulphide bridges. A minor fraction of the antibodies, however, reacts with determinants shared by the native and reduced forms of the peptide. This observation was consistent with physicochemical data (Engel et al., 1977) indicating that short N-and C-terminal sequences of peptide Col 1 are not involved in the rigid structure of the molecule. Since the amino acid sequence of peptide Col 1 has been established (Rohde et al., 1979) , we now attempted to localize the sequence-dependent antigenic determinants of peptide Col 1 to distinct regions of the peptide.
Materials and Methods

Fragments ofprocollagen peptide
The procollagen peptide Col I either in its native disulphide-bonded or in its reduced and S-carboxymethylated forms was isolated from dermatosparactic sheep skin as described previously (Becker Vol. 179 et al., 1976) . Tryptic peptides were prepared from reduced peptide Col 1 and purified by chromatographic methods (Rohde et al., 1979) . The order and size of these tryptic peptides are shown in Fig. 1 . Limited digestion of tryptic peptide TI (residues 1-24 of peptide Col 1) with staphylococcal proteinase V8 produced the fragments TISPI (residues 8-24) and TI SP2 (residues 1-7), whereas the smaller fragments TlSP2a (residues 4-7) and TlSP2b (residues 1-3) were obtained after a more drastic treatment with the same proteinase. Fragment TISPla (residues 12-24) was produced from fragment TISPI by a second cleavage with staphylococcal proteinase and purified on Bio-Gel P-4. Amino acid analysis shows that cleavage had occurred at the Glu-Asp bond (position 11-12) in fragment TISPI. Fragments Tla (residues 1-18) and Ti b (residues 19-24) were produced from an S-aminoethylated variant of peptide TI by a second trypsin treatment (Rohde, 1977; Rohde et al., 1979) . Fragment C1 was prepared from a chymopapain digest (Worthington, Freehold, NJ, U.S.A.; enzyme/substrate ratio 1:30; 24h at 37'C) of peptide TI and was purified by chromatography on a Bio-Gel P-4 column equilibrated in 0.2 M-ammonium bicarbonate, pH 8.5. Before use the enzyme was activated as described by Ebata & Yasunobu (1962) . The position of fragment Cl (residues 1-16) in peptide TI was established by amino acid analysis.
Antisera
The rabbit antisera to dermatosparactic type-I procollagen, poel(I) chain and peptide Col 1 were those used in a previous study (Rohde et al., 1976b) . T1 (24) T2 (4) T3-4 (35) T5 (29) T6 (6) TlSP2b TlSP2a ,
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T1SP2 (7) TlSP1 (17) I I Tla (18) Tlb (6) Cl (16) Fig. 1. Order ofthe tryptic peptides in procollagen peptide Col I and offurtherfragments obtainedfrom peptide Tl The fragments were obtained by cleavage with trypsin (T), staphylococcal proteinase (SP) or chymopapain (C). Numbers in parentheses refer to the numbers of amino acid residues in the peptides.
In addition, we used a single antiserum against reduced and S-carboxymethylated peptide Col 1.
Radioimmunoassay
Appropriate dilutions of the antisera were reacted with 1 or 2ng of 125I-labelled reduced and S-carboxymethylated peptide Col 1 (Rohde et al., 1976a) . In the inhibition assay fixed amounts of antibody were preincubated with non-labelled antigens before the addition of the labelled antigen. Immune complexes were finally separated from free antigen by precipitation with goat antiserum to rabbit immunoglobulin G. Results of the inhibition assays were expressed in percentage displacement of labelled antigen from antibody as described by Lotter & Timpl (1975) .
Results
Four out ofnine different antisera produced against various non-reduced procollagen antigens showed a distinct binding to labelled reduced peptide Col 1. The reaction could be equally well inhibited by native and reduced peptide Col 1, indicating that the antigenic determinants involved are shared by both forms of the peptide. A tryptic digest prepared from reduced peptide Col 1 also had strong inhibitory activity (Rohde et al., 1976b) .
In the present study we examined by inhibition assays whether antigenic activity could be localized on individual tryptic peptides of peptide Col 1 (Fig. 2) . The reaction of a single antiserum to pal(I) chain (no. 709) could be completely inhibited by the N-terminal peptide TI, and the inhibition curve found with TI was superimposable on that produced by the whole tryptic digest (Fig. 2a) . Other tryptic peptides either were inactive (T2, T6) or showed inhibition (T3-4, T5) only when used at 300-fold higher concentration compared with peptide TI. Presumably the inhibiting activity of peptides T3-4 and T5 is due to a small contamination with peptide TI. Studies with three other antisera (two against peptide Col 1, nos. 667 and 670, one against procollagen, no. 529) showed distinct inhibiting activity for three tryptic peptides, TI, T5 and T6 (Fig. 2b ). Since inhibition with each individual peptide did not exceed 30-40% of the total reaction, it is likely that different antibody fractions react with the different peptides. In support of this interpretation we found that an equimolar mixture of peptides TI, T5 and T6 was a better inhibitor than each individual peptide alone, even though the inhibition curve shown by the mixture did not completely approach the curve produced by the whole tryptic digest of peptide Col 1.
Further studies were carried out with the antiserum showing the exclusive reaction with peptide Ti (Fig. 2a) in order to localize antigenic activity on fragments prepared by proteolysis of peptide TI (see Fig. 1 ). In the inhibition assay (Fig. 3) peptide TI (residues 1-24) and its fragments (residues 1-7, 1-16 and 1-18) showed identical activity. Fragments from the central or C-terminal region of peptide TI (i.e. residues 8-24 and 19-24) were inactive. Cleavage of the active fragment (residues 1-7) to the smaller fragments (residues 1-3 and 4-7) destroyed antigenicity. We have also examined whether fragments with a length of three to eight amino acid residues prepared from peptide T5 by staphylococcal proteinase (Rohde et al., 1979) were antigenically active in an assay system similar to that shown in Fig. 2(b) . ( Figs. 2 and 3) , since the reaction could be inhibited by reduced peptide Col 1 but not by native peptide Col 1 (Rohde et al., 1976b) . On examination of tryptic peptides as inhibitors, only peptide TI was found to be active. In fact, the inhibition curves produced by the various peptides closely resembled those shown for another antiserum in Fig. 2(a) . Inhibition studies with proteolytic fragments of peptide Ti (Fig. 4) demonstrated distinct activity on peptide fragments representing residues 1-16, 1-18 and 8-24. Only 2-3-fold higher concentrations of these fragments were required to approach the inhibiting activity of peptide TI. Compared with peptide TI, a 100-fold lower activity was found for the fragment representing residues 12-24, whereas the N-terminal and C-terminal peptides (residues 1-7 and 19-24 respectively) were inactive.
Discussion
Structural analysis of peptide Col I (Rohde et al., 1979; Horlein, 1978) has demonstrated that the peptide is composed of two different sequence domains. The domain residues 1-86 comprises a non-collagenous segment showing an irregular distribution of glycine, whereas peptide T6 and the last six residues of peptide T5 (residues 87-98) have the collagen-like triplet structure Gly-X-Y. The ten cysteine residues of peptide Col 1 are found entirely in the non-collagenous domain and are distributed between position 18 in peptide TI and position 73 in peptide T5. The sequence-dependent antigenic determinants that are shared by the native and the reduced peptide Col I were found in the present study to be localized to the terminal regions of the peptide. These data resemble observations with other proteins such as myoglobin (Crumpton et al., 1970) , unfolded lysozyme and ferredoxin (Young & Leung, 1970; Kelly & Levy, 1971) , fibrinogen (Tanswell et al., 1977 (Tanswell et al., , 1978 and collagen , where sequence-dependent antigenic determinants have also been identified in terminal positions of the proteins.
Two of the antigenic determinants in native peptide Col 1 were found to be localized to a heptapeptide (TISP2, residues 1-7) from the N-terminus and to a hexapeptide (T6, residues 93-98) from the C-terminus of the molecule. The amino acid sequences of these peptides are shown in Fig. 5 . The small size of the peptides suggests that they comprise a single antigenic determinant. Fragments of comparable size have been found in other proteins to be antigenically active (Crumpton, 1974; . Cleavage of the Glu-Gly bond in the N-terminal heptapeptide abolishes antigenicity, and this in turn suggests that the determinant spans over the entire region of the peptide. The C-terminal hexapeptide is derived from the precursor-specific collagenous region of procollagen, which is assumed to exist in a triple-helical conformation in the native protein (Engel et al., 1977) . This antigenic determinant apparently becomes exposed on release of peptide Col 1 from procollagen or by denaturation of procollagen that may occur after injecting the protein into the rabbit. A further determinant was found on peptide T5, which is located close to the C-terminus of peptide Col 1. Here staphylococcal proteinase produced a number of small fragments (Rohde et al., 1979) that were inactive in the inhibition assay and thus did not allow us to localize the antigenic determinant precisely within the sequence.
In the studies with the antiserum to reduced peptide Col 1 no fragments with less than ten amino acid residues could be identified that still possessed distinct antigenic activity. However, results obtained with appropriate overlapping fragments indicate that the corresponding antigenic structure is localized in residues 8-16 of the sequence of peptide Col 1 (Figs. 4 and 5) . The observation that native peptide Col I is an ineffective inhibitor of these antibodies (Rohde et al., 1976b) indicates that this region of the molecule contributes to its rigid structure, whereas the adjacent sequence residues 1-7 has a random-coil structure. Since the sequence residues 8-16 does not contain cysteine, the unique antigenic specificity of reduced and carboxymethylated peptide Col 1 cannot be attributed to the chemical modification of the protein.
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